A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer

Clinical trial NCT02555644 · COMPLETED

Trial details

NCT number: NCT02555644
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2016-02-24
Primary completion: 2019-01-14
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.